APOE and Alzheimer disease: We found that miR-195 levels were reduced in parietal cortex tissues derived from ApoE4+/− mild cognitive impairment (MCI) and early AD subjects with clinical dementia rating (CDR) scores between 0.5 and 1 compared to levels in ApoE4−/− donors (Fig. 2a).